|
For:
|
Amstutz A, Schandelmaier S, Ewald H, Speich B, Schwenke JM, Schönenberger CM, Schobinger S, Agoritsas T, Tomashek KM, Nayak S, Makowski M, Morales-Ortega A, Bernal-Bello D, Pomponio G, Ferrarini A, Ghazaeian M, Hall F, Bond S, García-Morales MT, Jiménez-González M, Arribas JR, Guimaraães PO, Tavares CAM, Berwanger O, Yazdanpanah Y, Simensen VC, Lacombe K, Hites M, Ader F, Tacconelli E, Mentré F, Belhadi D, Massonnaud CR, Laouénan C, Diallo A, Baldé A, Assoumou L, Costagliola D, Ponzi E, Rueegg CS, Olsen IC, Trøseid M, Briel M. Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trials. Lancet Respir Med 2025;13:530-544. [PMID: 40378861 DOI: 10.1016/s2213-2600(25)00055-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/10/2024] [Revised: 02/13/2025] [Accepted: 02/14/2025] [Indexed: 05/19/2025] |